Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 16,320 shares at $514.67 ($8.5M) on 2025-11-13, disclosed to the SEC on 2025-11-14.
Scheduled sale ($8.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $514.67 | 146 | $75K | 0.9% |
| 2 | $514.67 | 146 | $75K | 0.9% |
| 3 | $515.64 | 919 | $474K | 5.6% |
| 4 | $515.64 | 919 | $474K | 5.6% |
| 5 | $517.51 | 645 | $334K | 3.9% |
| 6 | $517.51 | 645 |
| $334K |
| 3.9% |
| 7 | $518.53 | 835 | $433K | 5.1% |
| 8 | $518.53 | 835 | $433K | 5.1% |
| 9 | $519.67 | 1,355 | $704K | 8.3% |
| 10 | $519.67 | 1,355 | $704K | 8.3% |
| 11 | $520.68 | 308 | $160K | 1.9% |
| 12 | $520.68 | 308 | $160K | 1.9% |
| 13 | $521.79 | 1,094 | $571K | 6.7% |
| 14 | $521.79 | 1,094 | $571K | 6.7% |
| 15 | $522.70 | 1,434 | $750K | 8.8% |
| 16 | $522.70 | 1,434 | $750K | 8.8% |
| 17 | $523.66 | 811 | $425K | 5.0% |
| 18 | $523.66 | 811 | $425K | 5.0% |
| 19 | $524.49 | 153 | $80K | 0.9% |
| 20 | $524.49 | 153 | $80K | 0.9% |
| 21 | $526.68 | 120 | $63K | 0.7% |
| 22 | $526.68 | 120 | $63K | 0.7% |
| 23 | $527.85 | 200 | $106K | 1.2% |
| 24 | $528.60 | 440 | $233K | 2.7% |
| 25 | $530.21 | 40 | $21K | 0.2% |
| Total | $520.65 avg | 16,320 | $8.5M | 100% |
| Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |
| MDGL | SELL | 2024-04-03 | $4.1M | — | Filing → |